Skip to main content

Peer Review reports

From: A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

Original Submission
29 Jul 2020 Submitted Original manuscript
20 Oct 2020 Author responded Author comments - Yvonne LE Ang
17 Sep 2020 Reviewed Reviewer Report - Joseph Abi Jaoude
22 Sep 2020 Reviewed Reviewer Report
Resubmission - Version 2
20 Oct 2020 Submitted Manuscript version 2
2 Nov 2020 Author responded Author comments - Yvonne LE Ang
21 Oct 2020 Reviewed Reviewer Report - Joseph Abi Jaoude
26 Oct 2020 Reviewed Reviewer Report
Resubmission - Version 3
2 Nov 2020 Submitted Manuscript version 3
Publishing
4 Nov 2020 Editorially accepted
17 Nov 2020 Article published 10.1186/s12885-020-07616-4

You can find further information about peer review here.

Back to article page
\